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BIcell ! Acute! lymphoblastic! Leukemia! (BIALL)! is! characterized! by!monoclonal! and/or! oligoclonal! expansion! of! lymphoid! progenitor! cells!due! to! somatic! mutations(1). ! Malignant! progenitor! cells! rapidly!accumulate! in! the! bone! marrow,! supersede! normal! hematopoiesis! and!result! in!neutropenia, !anemia,!thrombocytopenia!and!dissemination!of!BIALL! cells! into! peripheral! blood.! Majority! of! diagnosed! adult! ALL,! about!75%,! belong! to! the! BIlineage! and! approximately! half! of! those! are! preIB!ALL(2). ! Apart! from! the! bone! marrow,! the! central! nervous! system! (CNS)!is! a! major! site! of! involvement! comprising! about! 8%! of! adult! patients! at!presentation!and!relapse!of!disease(3). !
Approximately! 6000! new! patients! are! diagnosed! annually! and!about! 1400! individuals! succumb! to! the! disease! in! the! United! States! (4). !In!United!States, !ALL!accounts! for!about!12%!of!all ! leukemias!diagnosed.!It ! is! the! most! common! type! of! cancer! in! patients! below! 15! years, !constituting! about! 25%! of! all ! pediatric! cancers! and! 75%! of! all ! pediatric!leukemias. ! Additionally, ! 20%! of! all ! adult! acute! leukemias! are! ALL.! The!disease! is! characterized! by! male! predominance! and! bimodal! age!incidence!peaking!at!1I4!years!and!>60!years(4). !
! ~!4!~!
ALL! cells! display! lack! of! differentiation! and! a! diffused! chromatin!structure.! Leukemic! cells! are! also! characterized! by! one! or!more! nucleoli !and! basophilic! cytoplasm.!However, ! it ! is!molecular! immunophetyping! by!flow! cytometry! that! is! primarily! used! to! diagnose! the! disease.! For!example, ! ALL! cells! from! the! BIlineage! typically! lack! myeloperoxidase! (a!marker!found!in!myeloid!cells). ! !
Genetic"Aberrations"in"B;ALL"
! Understanding! of! disturbed! gene! expression! levels! and! novel! gene!fusion! transcripts! has! significantly! improved! our! knowledge! of! ALL!progression.! Above! thirty! nonIrandom! translocations! have! been!observed! in! ALL.! The! preIdominant! mutation! in! ALL! involves! the! BCR;
ABL ! gene! reIarrangement! that! gives! rise! to! the! ‘Philadelphia!chromosome’, !which!is!found!in!about!20%!of!adult!ALL!cases. !The!fusion!gene! transcript! is! commonly! 190kDa! in! ALL! as! compared! to! 210kDa! in!Chronic! Lymphocytic! Leukemia! (CLL). ! The! identification! of! the! fusion!and!gene!and!its!mechanism!has!allowed!development!of!Tyrosine!Kinase!Inhibitors!(TKI)!for!Ph+!leukemias!(5). ! !
Apart! from! these! structural! abnormalities, ! ALL! cells! display!numerical! abnormalities! in! their! chromosomes.! Hyperdiploidy! is!observed! in! about! a! third! of! all ! pediatric! ALLs! and! is! associated! with! a!favorable! outcome! whereas! 15%! adult! cases! present! hyperdiploidy! and!association!with! a! positive! outcome! is! less! pronounced.! Hypodiploidy! is!
! ~!5!~!
observed! in! about! 2.8%! of! ALL! cases! presented! is! associated! with! a!worse!outcome(1). !
Treatment"
! Treatment! for! BIALL! typically! comprises! of! three! phases, ! namely, !remissionIinduction,!consolidation!or! intensification!and!maintenance!or!continuation! therapy.! After! the! induction! and! consolidation! therapies, !some!highIrisk!patients!are!given!stemIcell !transplantation(2,!3). !
! The!aim!of!the!remissionIinduction!therapy!is!to!eliminate!the!bulk!(99%)! of! leukemic! cell ! burden! from! the! patient! and! to! restore! healthy!performance! status! and! normal! hematopoiesis. ! A! threeIdrug! induction!approach! is! typically! used! for! standard! risk! pediatric! patients;! it !contains! a! glucocorticoid! (dexamethasone! or! prednisone), ! Vincristine,!and! a! third! drug! (which! can! be! either! asparaginase,! Anthracycline! or!both). ! For! highIrisk! children! and! all ! adult! patients, ! four! or! more! drugs!are! used! as! a! remission! induction! therapy.! The! exception! to! this!treatment! regimen! is! patients! with! mature! BIALL! where! the! induction!therapy! includes! cytarabine,! highIdose! methotrexate! and!cyclophosphamide.!Additionally, ! the! rate!of! remissionIinduction,! disease!free! survival! and! overall ! quality! of! l ife! of! Philadelphia! chromosome!positive! patients! has! been! significantly! improved! by! the! addition! of!Imatinib!mesylate! to! the! induction! phase.! Clinical! remission! can! now! be!achieved!in!up!to!93%!of!adult!and!99%!of!pediatric!ALL!patients. !
! ~!6!~!
! The! aim! of! the! intensification! therapy! is! to! eliminate! residual!drugIresistant! cells! to! decrease! the! relapse! risk. ! Although! the!importance! of! this! phase! of! treatment! is! widely! accepted,! there! is! l ittle!unanimity! in! the! duration! and! regimen.! Agents! that! are! commonly! used!in! this! phase! are! Vincristine,! highIdose! methotrexate! with!mercaptopurine! and! corticosteroid! with! highIdose! asparaginase.! A! reIinduction! therapy! with! agents! used! in! the! previous! phase! is! also!frequently!done.!
! The! most! intensive! phase! of! treatment! is! the! hematopoietic! stem!cell ! transplantation,! used!only! for!patients!with! a!highIrisk!prognosis! or!poor! response! to! first! line! therapy! owing! to! significant! morbidity! and!mortality!associated!with!the!treatment. !
! For! reasons! yet! unknown,! continuation! therapy! is! required! by! BIALL! patients! to! prevent! relapse.! Therefore, ! all ! patients! are! prescribed!chemotherapy! for! about! two! years. ! A! daily! dose! of! methotrexate! and!mercaptopurine! is! commonly! used! as! the! backbone! of! continuation!therapy.!
! Some!studies!report!up! to!30I40%!initial ! relapses!owing! to!Central!Nervous! System! (CNS)! involvement, ! identified! primarily! by! presence! of!leukemic! cells! in! the! cerebrospinal! fluid. ! Other! factors! such! as! highIrisk!genetic! abnormalities! and! hyperIleukocytosis! are! also! associated! with!
! ~!7!~!
CNS! involvement. ! Cranial! irradiation! is! used! in! a! low! percentage! of!patients!due!to!complications!associated!with!the!procedure.!
Response"rates"









Figure! 1.! The! role! of! CXCR4! in! normal! and!malignant! hematopoietic!
cell! homing! to! the! bone! marrow ! (15). ! Both! normal! (HSC,! left! hand!side)! and! malignant! (Leukemia,! right! hand! side)! hematopoietic!progenitor! cells! express! CXCR4! to! home! to! the! bone!marrow.! Both! these!cell ! types! follow! a! CXCL12! gradient! that! is! constitutively! secreted! by!stromal! cells! in! the! bone! marrow.! These! intricate! netlike! stromal! cells!with! excessive! CXCL12! secretion! are! often! situated! adjoining! the!vascular!network! called! ‘sinusoids’ . ! These! sinusoids! along!with! reticular!stromal! cells! form! a! ‘vascular! niche’!where! BIALL! cells!migrate!with! the!help!of!CXCR4.! !
Figure!taken!with!permission!from:!Burger! JA,!Burkle!A.!The!CXCR4!chemokine!receptor! in!acute!and!chronic!leukaemia:! a! marrow! homing! receptor! and! potential! therapeutic! target. !
Br"J "Haematol . !2007;137(4):288I296.!!! !
! ~!11!~!
CXCL12!engages! its! cognate! receptor!CXCR4! to!attract!and!confine!BIALL!cells! to! BMSCs.! Both! CXCL12! and! CXCR4! knockout! mice! display! severe!defects! in! B! lymphopoiesis! highlighting! the! importance! of! this! axis! in!normal! BICell ! development(16,! 17). ! Both! normal! precursor! BIcells! (12,!18I20)! and! leukemia! cells(21I23)! share! this!mechanism! to!home! to! their!bone! marrow! niches. ! PrecursorIBIcell ! ALL! is! characterized! by! the!predisposition!to!infiltrate!extraImedullary!sites, ! for!example!the!central!nervous! system,! liver, ! spleen! and! lymph! nodes.! However, ! the!major! site!of! involvement! is! in! the!bone!marrow!microenvironment. !The!CXCR4!and!integrin! mediated! interaction! between! the! bone! marrow! stroma! and!leukemia!cells!protects!them!from!chemotherapy!induced!or!spontaneous!apoptosis! and! is! a! mechanism! to! account! for! chemotherapy! resistance!that! eventually! leads! to! minimal! residual! disease! and! subsequent!relapse. ! !
! Minimal! residual! disease! in! defined! as! the! remainder! of! leukemic!cells! in! the!bone!marrow!of!ALL!patients!during!or! after! treatment!when!the! patient! is! in! remission.! MRD! has! immense! prognostic! value!throughout! the! treatment! of! leukemia,! so! much! so! that! it ! surpasses! the!impact! of! other! clinical! and! biological! parameters. ! For! instance,! the!AIEOPIBFM!ALL!2000!study! reported! that! for!pediatric!BIALL!prognostic!risk! classification! based! on! MRD! measurements! on! treatment! days! 33!and! 78! was! better! than! prior! criteria! based! on! age,! leukocyte! count, !genetic! subtype! and! early! response! to! therapy(24). ! Additionally, ! a!
! ~!12!~!
plethora! of! independent! studies! have! shown! MRD! to! be! a! robust!prognostic!marker!in!adult!ALL!as!well . ! !
The!mouse!model!with!the!CXCR4!or!CXCL12!gene!deletion!resulted!in! early! release! of! BIcells! into! circulation(19). ! CXCR4! has! also! been!reported! to! participate! in! homing!of!BIALL! cells! to! bone!marrow! in! nonIobese! diabetic! severe! combined! immunoIdeficient! (NOD/SCID)! mice(22,!25). ! BIALL! cells! have! been! characterized! by! a! distinctive! signature! of!high! CXCR4! expression! that! leads! to! pertussis! toxin! sensitive!downstream! signaling! in! which! VLAI4! integrin! has! critical!important(22). ! Direct! in" vivo" evidence! of! CXCR4! involvement! has! also!been! provided! by! Sipkins! et! al ! (2004)(23)! who! used! in" vivo ! confocal!microscopy!to!report!that!CXCR4!is!required!for!BIALL!cell !homing!to!the!murine! bone!marrow! niche.! The! use! of! CXCR4! antagonists! demonstrated!disruption! of! the! leukemiaIbone! marrow! interaction.! Additionally, ! the!development! of! the! earliest! precursor! B! cells! is! highly! dependent! on!CXCL12! and! it ! is! also! a! potent! chemoIattractant! for! pre! and! pro! B! cells. !CXCR4! has! been! reported! to! be! expressed! and! functional! in! BIALL! cells, !causing!chemotaxis!and!spontaneous!migration!underneath!bone!marrow!stromal! cells. ! BIALL! cell ! l ines! like! NALM6! and! REH! require! CXCR4! and!other! adhesion! molecules! such! as! CD49D! (VLAI4)! integrin! to! undergo!migration! mentioned! above(26,! 27)! and! these! data! have! been! also!confirmed! in! patient! samples(28,! 29). ! This! response! of! BIALL! cells! has!been! reported! to! be! dependent! upon! the! p38! MAPK! signaling!
! ~!13!~!
pathway(30). ! Consequently, ! inhibition! of! CXCR4! in! BIALL! cells! with!highly! specific! antagonists! has! been! reported! to! block! migration! of!leukemia! cells! to! CXCL12! and! partially! disrupt! stroma! mediated! drug!resistance(31). !
Considering! the!above! facts, !molecular! interactions!between!BIALL!cells! and! the! BM! microenvironment! must! be! identified! and! effectively!targeted!in!order!to!improve!survival!any!further. !
The!CXCR4!Chemokine!Receptor!
Structure:"gene"and"protein"
! CXCR4,!also!known!as!Fusin!or! cd184,!was! first!discovered!as!a! coIfactor! involved! in! the!entry!of!TITropic! strain!of!HIVI1! into!CD4!positive!T! cells. ! The! CXCR4! gene! is! located! at! genetic! locus! 2q21,! contains! two!exons! separated! by! an! intron! (spanning! 2.1! kb)! and! the! cDNA! open!reading! frame! is! 1659! bp! long.! ! A! typical! upstream! promoter! region! is!observed! at! the! 5’! flanking! region! of! the! CXCR4! open! reading! frame!spanning! 2.6! kb!with! a! TATA! box! 30bp! upstream!of! a! transcription! start!site(32,!33). ! !
The! protein! is! 352! amino! acids! long! and!has! a!molecular!weight! of!about! 39kDa! containing! an! NIterminal, ! seven! transImembrane! domains, !three! intraIcellular! loops! (ICL), ! three! extraIcellular! loops! (ECL)! and! a! C!terminal. ! Its! structure! is! represented! in! Figure! 2. ! It ! is!widely! expressed!
! ~!14!~!







Figure!2 . !Structure!of!CXCR4 . ! Shown!here! is!protein!sequence!depicting!NIterminal, ! extracellular, ! transImembrane,! intracellular! and! CIterminal!domains! of! CXCR4.! The! four! Aspartate! (D)! residues! involved! in! the!interaction! of! CXCR4! and! Plerixafor! (AMD3100)! are! highlighted! in!red(35). !











Figure! 3.! Structure! of! CXCR4! in! complex! with! its! natural! ligand!
CXCL12(36) . ! Schematic! shows! model! of! interaction! between! CXCR4! and!its! ligand!CXCL12! (SDFI1). ! The! seven! transImembrane!helix! domains! are!represented! as! cylinders! that! are! connected! to! each! other! by! extra! and!intra! cellular! loops.! CXCL12! is! shown!above!CXCR4!as! a! ribbon! structure!(MOLSCRIPT! diagram).! (A)! CXCL12! and! CXCR4! are! shown! separately!before! any! contact! between! the! two.! (B)! The! two! contact! regions!between!CXCL12! and!CXCR4! are! shown!blue! and! orange.! The! blue! region!depicts! contact! between! the! CXCR4!NIterminal! and! CXCL12!RFFESH! loop!both! of! which! are! more! truncated! as! compared! to! the! unbound! states. !The! orange! region! depicts! CXCL12! NIterminal! binding! to! the! groove!above!extracellular!domains!of!CXCR4.!
Adapted!with!permission!from!Crump,! M.! P. , ! J . ! H. ! Gong,! P. ! Loetscher, ! K. ! Rajarathnam,! A.! Amara,! F. !ArenzanaSeisdedos,! J . ! L. ! Virelizier, ! M.! Baggiolini, ! B. ! D. ! Sykes, ! and! I . !ClarkLewis. ! 1997.! Solution! structure! and! basis! for! functional! activity!of!stromal!cellderived! factor1;!dissociation!of!CXCR4!activation! from!binding!and!inhibition!of!HIV1.!The"EMBO"journal"16:!6996I7007.!!! !
! ~!19!~!
Mutant! studies! revealed! that! the! CXCR4!N! terminal! is! essential! for!CXCL12! binding.! Also, ! CXCL12! interacts! with! the! second! extracellular!loop! to! activate! downstream! signaling! pathways! and! the! AspIArgITyr!motif! located! at! the! second! intracellular! loop! is! required! for! CXCR4!activation.! Additionally, ! the! HIVI1! coIfactor! function! and! the! signaling!function!are!independent!of!each!other(37). !
CXCL12:"The"CXCR4"ligand"
There! are! two! main! types! of! classifications! that! exist! for!chemokines. ! The! first! type! of! classification! is! based! on! the! relative!position! of! the! first! two! of! four! cysteine! residues, ! giving! rise! to! four!subfamilies:! CC,! CXC,! C! and! CX3C.! The! second! type! of! classification!divides! chemokines! into! two! groups,! namely, ! inflammatory! or!homeostatic(38). ! Inflammatory! chemokines! are! expressed! in! an! acute!and! transient! manner! to! attract! inflammatory! cells! to! sites! of! infection!or! injury.! Homeostatic! chemokines, ! on! the! other! hand,! are! expressed!constitutively. ! CXCL12,! also! known! as! Stromal! cellIDerived! Factor! 1!(SDF1)! and! originally! isolated! from!murine! bone!marrow,! belongs! to! the!‘homeostatic’ ! group!of! chemokines!and!was! initially!discovered!as!a!preIBIcell !growth!stimulating!factor(39,!40). ! !
! ~!20!~!
The! CXCL12! gene! displays! high! degree! of! evolutionary!conservation! and! is! located! on! chromosome! 10q.! Various! splice! variants!of! CXCL12! (α,! β, ! γ, ! δ, ! ε! and! φ)! have! been! described,! with! the! 89! amino!acid! α! isoform! (3! exons)! being! expressed! preIdominantly(40,! 41). !CXCL12! β,! γ, ! δ, ! ε! and!φ! contain! 4, ! 30,! 31,! 1! and! 51! amino! acid! extension!at! their! CIterminus! domain! as! compared! to! the! α! variant(41). ! The!functional! significance! of! these! isoforms! is! poorly! understood! but! it ! is!known! that! they! display! differential! distribution! in! various! tissues. ! The!present! study! focused! on! the! α! variant! owing! to! lack! of! γ, ! δ, ! ε! and! φ!isoform!expression!in!the!bone!marrow(41). !
CXCL12α!is!secreted!constitutively!by!the!bone!marrow!stroma!and!signals! through! CXCR4.! CXCL12! is! characterized! as! a! potent! inducer! of!directional! migration! in! a! range! of! cells! of! hematopoietic! origin(9,! 42)!and!along!with!CXCR4,! it !plays!a!critical!role! in!the!trafficking!of! immune!and! hematopoietic! cells! to! various! tissue! microenvironments. ! High!continuous! expression!of!CXCL12!by!bone!marrow!stromal! cells! suggests!its! important! role! in! the! marrow! microenvironment. ! Concurrently, !various! in" vitro" and! in" vivo ! studies! demonstrate! that! this! chemokine! is!essential! for! hematopoietic! cell ! homing! and! retention! in! the! bone!marrow(8,! 10). ! In! fact, ! hematopoietic! stem! cells! selectively! migrate! to!CXCL12! and! not! to! other! chemokines(43)! and! it ! is! required! for! bone!marrow!stem!cell !retention(20,!44,!45). !
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Mice! lacking! the!CXCL12!gene!display!phenotypical! resemblance! to!CXCR4! gene! deletion! mice! with! deficient! myelopoiesis! and! BIlymphopoiesis, ! and! abnormal! development! of! the! heart! and! neurons(16,!17,! 46). ! This! similarity! in! phenotype! had! initially! suggested! that! this!chemokine! and! receptor! pair! is!monogamous! in! nature.! However, ! recent!studies! by! various! groups! have! confirmed! that! CXCL12! binds! to! a! novel!receptor!CXCR7!also(47,!48). !This! receptor! is!discussed! in!detail !on!page!28.!
Regulation"of"CXCR4"signaling"
In! order! to! have! a! clear! picture! of! the! role! of! CXCR4! in! human!disease!it ! is!imperative!to!have!a!fundamental!understanding!of!signaling!mechanism. "The! binding! of! CXCL12! to! CXCR4! is! proposed! to! be! a! 2Istep!process, ! the! first! step! involves! residues! 12I17! of! CXCL12! and! 2I36! of!CXCR4! that! cause! a! conformational! change! in! the! receptor. ! This!conformational! change! exposes! a! binding! pocket! in! the! second! and! third!extracellular! loops! of! CXCR4! that! interacts! with! the! first! eight! amino!acids!of!CXCL12.!This!constitutes!the!second!step!of!the!interaction(49). "
!There! are! two! types! of! CXCR4! signaling! that! has! been! discovered;!G!protein!coupled!and!G!protein! independent. ! In! its!basal! state, !CXCR4,!a!G! protein! coupled! receptor! has! an! intracellular! heterotrimer! of! G! α, ! β!and! γ! subunits! that! are! bound! to! guanine! nucleotide! GDP.! The! CXCL12ICXCR4! binding! activates! the! receptor! by! replacing! GDP!with! GTP,! due! to!
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which! the!βγ!dimer! is!dissociated! from! the!heterotrimer.!The!Gα! subunit!can!then!activate!various!signaling!pathways,! for!example!it !activates!Src!family! of! kinases. !On! the! other! hand,! the!Gβγ! subunit! has! been! shown! to!activate! the! phosphoinositideI3! kinase! (PI3K)! and! the! JAK/STAT!pathways.! These! pathways! ultimately! lead! to! processes! like! migration,!cell !adhesion!and!gene!transcription(50). !


























Figure! 4.! CXCR4! regulation.! Figure! depicts! different! levels! of!
regulation! of! CXCR4 . ! CXCR4! expression! is! affected! at! the! transcription!level! by! various! processes! e.g. ! inflammation,! hypoxia! tissue! damage!through!various!proteins. !For!example, !CXCR4!expression!is!upIregulated!by! HIFI1! and! NFκB! and! downIregulated! by! VHL.! Both! CXCR4! and! its!ligand! CXCL12! are! susceptible! to! proteolytic! degradation! by! various!proteases! in! the! microenvironment. ! Upon! CXCL12! binding,! CXCR4!undergoes! rapid! and! dynamic! internalization! into! endosomal!components! and! CXCL12! depletion! has! been! reported! to! restore! surface!CXCR4! expression.! Several! post! translation! modifications! have! been!reported! for! CXCR4! that! alter! its! function.! For! instance,! various!phosphorylation! sites! having! positive! or! negative! effects! on! CXCR4!signaling! have! been! identified.! Additionally, ! glycosylation! at! Asn11!decreases! binding! to! CD4! positive! T! cells! whereas! it ! is! essential! for!binding! to! CXCL12.! The! function! of! the! CXCR4! protein! depends! upon! its!inclusion! in! lipid! rafts, ! which! can! be! regulated! by! signals! from! other!membrane! proteins. ! Finally, ! CXCR4! has! been! shown! to! undergo!dimerization! with! itself ! and! CXCR7,! which! has! an! effect! on! the!downstream!signaling!pathways!(51,!52). ! !
" "
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Apart! from! transcriptional! regulation,! CXCR4! function! is! regulated!in! several! other! ways.! The! extracellular! domains! of! CXCR4! have! two!glycosylation! sites, ! Asn11,! that! is! involved! in! HIV! and! CXCL12! binding.!Another! postItranslational! modification! that! regulates! ligand! binding! is!tyrosine!sulfation!at!Tyrosines!1, !12!and!21!out!of!which!Tyr!21!accounts!for!the!most!sulfation.!
Another! level! of! regulation! that! affects! CXCR4! function! is! its!oligomerization.!The!functional!significance!of!CXCR4!dimerization!is!not!yet! understood! well , ! although! it ! has! been! proposed! that! homoIdimerization! is! necessary! to! enhance! response! to! CXCL12! and! stimulate!G! protein! independent! stimulation! of! the! JAK/STAT! pathway.!Additionally, ! CXCR4! heteroIdimerization! with! CXCR7! stimulated! by!CXCL12! has! been! reported! to! activate! G! protein! independent! βIarrestin!signaling.! Taken! together, ! these! data! suggest! homo! and! heteroIdimerization!regulates!nonIcanonical!signaling!in!the!absence!of!CXCL12.!







Figure! 5.! The! CXCR4! signaling! network(53). ! CXCL12! acts! through! its!receptor! CXCR4.! Engagement! of! CXCR4! with! CXCL12! activates! an!intricate! signaling! network! that! promote! calcium! mobilization,!chemotaxis, !survival, !proliferation!and!transcription.!














Figure!6.! The!CXCR4/CXCR7! signaling!pathways(55). ! CXCL12! binds! to!both! CXCR4! and! CXCR7! and! leads! to! activation! of! various! signaling!pathways!dependent!upon! tissue! types. !CXCR7!has!been!mainly! shown! to!sequester! CXCL12! away! from! CXCR4,! thus! affecting! CXCR4! function.!However, ! recent! studies! have! shown! that! CXCR7! can! activate! the! MAP!kinase!pathway!through!βIarrestin!in!numerous!systems!tested. !




Apart! from! being! responsible! for! chemotaxis! of! leukemia! cells! to!the! bone! marrow(56), ! engagement! of! CXCR4! also! helps! in! adhesion! to!BMSCs! and! activates! various! signaling! cascades! providing! the! cells! with!direct! survival!advantage(22). !As!a! result! leukemia!cells! in!bone!marrow!niches! may! become! resistant! to! chemotherapeutic! drugs. ! This! drug!resistance!mechanism! is! appropriately! known!as!Cell !Adhesion!Mediated!Drug! Resistance! (CAMIDR)! and! accounts! for! Minimal! Residual! Disease!(MRD)! in! bone! marrow! niches! and! the! consequent! relapse! of! ALL.!Clinically!CXCR4!expression!has!been! shown! to!be!associated!with!worse!outcome! in! BIALL! patients(57I59). ! Consequently, ! inhibition! of! this! axis!presents! itself ! as! an! alluring! strategy! for! prevention! of! relapse.! Indeed,!Plerixafor!(Mozobil !or!Previously!AMD3100),!a!reversible!small !molecule!CXCR4! inhibitor, ! has! been! FDA! approved! for! stem! cell ! mobilization! for!NonIHodgkin! lymphoma! and! Multiple! Myeloma(60). ! It ! has! also! been!shown! to! mobilize! ALL! cells! from! bone! marrow! niches! to! peripheral!blood! in! mice(61). ! Additionally, ! Plerixafor! is! being! currently! tested! in!clinical! trials! as! a! chemoIsensitizing! agent! for! Acute! Myeloid!Leukemia(62). ! In! this! study,! we! demonstrate! that! inhibiting! CXCR4!disrupts! the! ALLIBMSC! interaction! thus! overcoming! Cell ! Adhesion!Mediated!Drug!Resistance! provided! to!ALL! cells! by!BMSCs.! Furthermore,!apart! from! the! effect! of! pharmacological! inhibition! of! CXCR4! on!
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chemotaxis, !adhesion!and!chemoIsensitivity, !we!report!an! in!vitro!and! in!vivo!genetic!deletion!model!of!CXCR4!from!BIALL!cells. !
CXCR4!inhibitors!
Plerixafor:"the"bicyclam"story"
! Plerixafor!also!known!as!AMD3100!or!Mozobil !was!derived!from!an!earlier! compound,! JM1657,!which! in! turn!was! discovered! as! an! impurity!in!monocyclam! compound! commercially! prepared! for! its! activity! against!HIV.! The! failure! in! reIsynthesis! of! JM1657! led! to! development! of!bicyclam! compounds! in!which! two! cyclam!moieties! are! tethered! through!and! aromatic! bridge! (Figure! 7). ! After! the! synthesis! of! several! bicyclams,!a! quantum! leap! was! achieved! in! antiIHIV! activity! by! the! synthesis! of!AMD3100! (AMD! stands! for! AnorMeD,! the!manufacturer! at! the! time). ! The!viral! protein! gp120,! involved! in! HIV! cell ! entry! was! identified! as! an!indirect! target! and! later! CXCR4,! due! to! its! role! as! a! coIreceptor! in! HIV!cell !entry,!was!identified!as!the!direct!target!for!Plerixafor. ! !
! Owing! to! its! potential! as! a! potent! antiIHIV! agent, ! there! was!considerable! enthusiasm! for! clinical! use. ! The! clinical! studies! however, !showed! an! increase! in! white! blood! cells! counts! of! patients! peaking! 8! to!10!hours!post!subIcutaneous! injections. !These!white!blood!cells! included!CD34! positive! hematopoietic! progenitor! cells. ! Consequently, ! Broxmeyer!et! al ! 2005! (63)demonstrated! that! plerixafor! could! effectively! mobilize!
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hematopoietic! stem! and! progenitor! cells! from! their! niches, ! thus! giving!rise! to! the! concept! of! plerixafor! as! a! potent! mobilizer! of! HSCs.! This!mobilization! was! a! clear! outcome! of! CXCR4! inhibition! in! patients. !Consequently, ! Mozobil ! or! plerixafor, ! in! combination! with! granulocyteIcolony! stimulating! factor! (GICSF), !was!approved!by! the!FDA! in!2008!as!a!stem! cell !mobilizer! in! patients!with!Multiple!Myeloma! or! NonIHodgkin’s!Lymphoma.!










Figure! 7. ! Structure! of! Plerixafor! (66). ! Plerixafor, ! also! known! as!AMD3100! and! Mozobil , ! is! a! bicyclam! containing! two! cyclam! (1,4,8,11Itetraazacyclotetradecane)!moieties! tethered! through! an! aromatic! bridge![phenylenebis(methylene)]. !





BKT140,! or! 4FIbenzoylITN! 14003! is! a! novel, ! potent! 14Iresidue!synthetic! bioIstable! peptide! which! binds! selectively! to! CXCR4! with! an!affinity!of!84!nmol/L!as!compared!to!plerixafor!which!has!an!affinity!of!4!nmol/L.! It ! is! a! reversible! inhibitor! that! dissociates! from! CXCR4! with! a!much! slower! pace! than! plerixafor. ! Additionally, ! unlike! plerixafor! that! is!a!weak!partial!agonist! for!CXCR4,!BKT140!completely!shuts!down!normal!signaling! cascades! downstream! of! CXCR4.! Furthermore,! BKT140,! unlike!plerixafor, ! does! not! activate! βIarrestin! signaling! downstream! of! CXCR7.!BKT140! is! in! clinical! trials! for!patients!with! acute!myeloid! leukemia!and!chronic!myeloid!leukemia!for!improving!the!outcome!of!chemotherapy.!
Summary!and!Hypothesis!













Reagents!and!Antibodies!Synthetic! human! CXCL12! or! SDF1α! was! purchased! from! R&D!Systems! (MN,! USA).! The! small!molecule! CXCR4! inhibitor, ! Plerixafor, !was!purchased! from! SIGMAIALDRICH! (St. ! Louis, ! MO,! USA)! and! BKT140!peptide! CXCR4! inhibitor! was! kindly! provided! by! Dr. ! Amnon! Peled!(Goldyne! Savad! Institute! of! Gene! Therapy,! Hadassah! Hebrew! University!Hospital , ! Jerusalem,! Israel). !Dexamethasone!and!Vincristine! sulfate!were!purchased! from!SIGMAIALDRICH!(St. !Louis, !MO,!USA)!and!4IHydroperoxy!Cyclophosphamide! was! purchased! from! Santa! Cruz! Biotechnology!(Dallas, ! TX,! USA).! The! antiICXCR4Iphycoerythrin! (PE)! (12G5)! antibody!was! purchased! from! BD! Pharmingen! (San! Jose, ! CA,! USA)! and! the! antiICXCR4IAllophycocyanin! (APC)! (12G5)! antibody! was! purchased! from!eBioscience! (San! Diego,! CA,! USA).! AntiIhuman/miceICXCR7IPE! antibody!clone! 8F11IM16! was! purchased! from! Biolegend! (San! Diego,! CA). ! All ! the!other!antibodies!used:!antiICD44Ifluoroscein!isothiocyanate!(FITC), !antiICD54IPE,! antiICXCR5IPE,! antiICXCR3IPE,! antiICD62LIFITC,! antiICD49DIPE! and! CCR7IPE! were! purchased! from! BD! Pharmingen! (San! Jose, ! CA,!USA). "!
Cell!culture!Murine!bone!marrow!stromal! cell ! l ine!9I15C! (from!C3H/He!mouse)!and! all ! the! BIALL! cell ! l ines! were! purchased! from! the! RIKEN! Cell ! Bank!(Ibaraki, ! Japan). ! Cells! were! cultured! in! RPMI! 1640! medium!
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supplemented! with! 10%! FBS! (Gibco,! Grand! Island,! NY), ! 2.05! mM! LIglutamine! and! penicillinIstreptomycin! (Cellgro). ! BIALL! xenograft! cells!were! a! kind! gift ! from! the! Müschen! Laboratory! (UCSF,! CA)! and! were!maintained!in!Aplha!MEM!medium!containing!20%!FBS,!Sodium!Pyruvate, !GlutaMAX!and!pencillinIstreptomycin.!!
Chemotaxis!assay!The! migration! of! BIALL! cells! to! CXCL12! was! quantified! using! 24Iwell! transwell ! plates! (Corning! Life! Sciences, ! Acton,! MA)! as! described!previously(67). ! In! brief, ! polycarbonate! inserts! in! chemotaxis! transwell!chambers!with! a! pore! size! 5μm!were! used,! and! 5x106!BIALL! cells, ! in! 100!μL,! were! added! to! the! top! chamber,! while! CXCL12! (100! ng/ml)! was!added!to! the! lower!wells. !The!plates!were! incubated!at!37°C!after! inserts!were! placed! into! the! wells. ! RPMI! 1640! supplemented! with! 0.5%! bovine!serum! albumin! (assay! media)! without! CXCL12! was! used! as! control. ! The!plate! was! incubated! for! 3! hours! and! assay! media! in! the! lower! chamber!containing! migrated! was! collected! and! counted! in! the! flow! cytometer!(FACSCalibur)! for! 20! seconds! at! high! flow.! As! a! control, ! a! dilution! of!input!cells!(1:20)!was!counted!in!the!same!experimental!conditions.!!
Pseudoemperipolesis!(in!vitro!migration!of!ALL!cells!under!BMSCs)!Pseudoemperipolesis! is! a! CXCR4! dependent! in" vitro ! phenomenon!where! leukemia! cells! spontaneously!migrate! underneath! BMSCs. ! Briefly, !
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day! before! the! assay,! 9x104! 9I15C! murine! bone! marrow! stromal! cells!were! plated! per! well ! in! 24Iwell! plates. ! On! the! day! of! the! experiment, !stromal! cell ! layer! confluence! was! examined! using! phaseIcontrast!microscopy,! and! 2.5x106!treated! or! untreated! leukemia! cells!were! added!to! each! well . ! ALL! cells! were! preIincubated! with! 10! μg/ml! CXCR4!inhibitors! (Plerixafor/BKT140)! for! 1! hour! at! 37°C.! After! 4! hours!incubation! at! 37°C,! and! nonImigrated! cells! in! suspension! were! removed!by! thorough!washing!of!each!well !3! times!with!RPMI!1640!medium!while!being! careful! of! not! washing! away! stromal! cell ! layer. ! Stromal! cell ! layer!with! migrated! leukemia! cells! was! trypsinized! and! suspended! in! 500! ml!RPMI!1640!supplemented!with!10%!FCS!and!counted! in!a! flow!cytometer!for! 20s! at! high.! A! lymphocyte! gate! using! the! forward! and! side! scatter!was!set!to!exclude!the!stromal!cells. !!
Cell!Viability!Measurement!Viability! was! measured! using! the! following! protocol. ! Cells! were!incubated! for! 25!minutes! in! FACS! buffer! (RPMI! 1640! supplemented!with!0.5%!BSA)!containing!40!nM!3,3’Idihexyloxacarbocyanine! iodide! (DiOC6)!and!propidium!iodide!(PI, !10!μg/mL)!and!the!cells!were!then!analyzed!by!flow! cytometry! (FACS! Calibur, ! BD! Biosciences, ! San! Jose, ! CA)! within! 30!minutes. ! Cells! displaying! low! PI! and! DiOC6! fluorescence! are! apoptotic. !On! the! other! hand,! cells! with! low! high! DiOC6! and! low! PI! are! viable. !Lastly, ! high! PI! and! low! DiOC6! fluorescence! in! cells! is! representative! of!
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necrosis. !!
Cell!Adhesion!Mediated!Drug!Resistance!(CAMRDR)!Experiments!To! determine! if ! stromal! cells! can! rescue! BIALL! cells! from! drug!induced! cytotoxicity! and! if ! CXCR4! antagonism! can! abolish! this! rescue,!ALLIBMSC! coIculture! experiments! were! conducted! with! and! without!cytotoxic! drugs! (Dexamethasone,! Vincristine! and! 4IHydroperoxy!cyclophosphamide)! and! CXCR4! antagonists! (Plerixafor! and! BKT140).!Briefly, ! the! day! before! starting! the! assay,! 9I15C! stromal! cells! were!seeded! in! 24Iwell! plates! at! a! concentration! of! 2x104! cells/well . ! After!overnight! incubation,! phase! contrast! microscopy! was! used! to! assess!confluence! of! the! stromal! cell ! layer, ! and! treated! and! untreated! leukemia!cells! were! added! into! each! well ! to! a! final! concentration! of! 1x106! ALL!cells! per! well . ! ALL! cells! were! preIincubated! with! 10! μg/ml! CXCR4!inhibitor! (Plerixafor! and! BKT140)! for! 1! hour! at! 37°C.! Cytotoxic! drugs!Dex! or! Vin! were! added! at! the! indicated! concentrations.! For! 4IHydroperoxy! Cyclophosphamide,! cells! were! treated! with! indicated!concentrations! for! 45! minutes! and! then! washed! with! culture! media!before!plating!on! stromal! cells. !ALL! cells! alone,! in! coIculture!with!9I15C!and! with! the! cytotoxic! drug! were! used! as! controls. ! Viability! of! cells! in!the! supernatant! was! measured! at! 48Ihour! time! point. ! Where! indicated,!viability! of! ALL! cells! that! migrated! under! the! 9I15C! (through! PEP)! was!also!measured.!
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!
CRISPRRCas9!based!CXCR4!Knockout!CXCR4! knockout! cell ! l ines! were! generated! using! the! CRISPR! Cas9!gene! editing! system.! Briefly, ! a! unique! 20! bp! target! sequence! located! on!the! second! transImembrane! domain! of! CXCR4! was! used! to! generate! the!guide! CRISPR! RNA! that! was! ligated! into! px330! plasmid! (Addgene,! MA)!under! the! control! of! the! hU6! promoter. ! The! Cas9! sequence! was! ligated!into! the! same! plasmid! under! the! control! of! the! AmpR! promoter. ! The!plasmid! was! transfected! into! the! ALL! cells! by! electroporation! with! the!Neon! Transfection! System! (Life! Technologies, ! NY)! using! the! conditions!1500! Volts, ! 20! milliseconds! and! 1! pulse. ! After! 48! hours! the! CXCR4!expression! was! analyzed! using! FACS! analysis. ! The! negative! cell !population!was!enriched!using! two!rounds!of!MACS!cell !sorting!(Miltenyi!Biotec, ! CA). ! For!MACS! sorting, ! the! cells!were! stained!with!PE! conjugated!CXCR4! antibody! for! 15! minutes! at! 4°C,! washed! and! then! stained! with!antiIPE! microbeads! for! 15! minutes! at! 4°C! before! passing! through! the!MACS! LD! column.! The! CXCR4! negative! cells! were! collected! in! the! flow!through!and!stained!with!APC!conjugated!CXCR4!antibody!after!48!hours. !!
Growth!assays!! Growth! rates! of! wild! type! and! knockout! cell ! l ines! were! compared!by! plating! 1! x! 106 ! cells! for! each! cell ! l ine! in! 24! well ! plates. ! Cells! were!counted! for! 20! seconds! at! high! at! 0, ! 24,! 48! and! 72! hours! using! a! flow!
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cytometer!(BD!FACS!Calibur). !
GFP!transfection!HEK293T! cells! were! transfected! with! (5μg)! lentiviral! plasmid! and!packaging! plasmids! pMD2.G! (5μg)! and! pPAX! (5μg)! using! Jet! prime!transfection! reagents! according! to! the! manufacturers! protocol. ! The!medium! containing! the! virus! was! collected! at! 48! hours, ! centrifuged! at!1500! rpm! for! 5! minutes! and! supernatant! filtered! through! a! 0.45! μm!filter. ! NALM6!WT! and!NALM6ICXCR4IKO!were! reIsuspended! in! 5ml! viral!supernatant! and! incubated! overnight! at! 37°C.! Viral! media! was! replaced!with! fresh!media! the!next!day! and!GFP!expression!was! analyzed! after!48!hours. !!
In#vivo !experiments!All! mice! experiments! were! performed! in! accordance! with! a!protocol! approved! by! the! Institutional! Animal! Care! and! Use! Committee!of!MD!Anderson!cancer!center. !To! investigate!the! in"vivo !effects!of!CXCR4!in! NALM6! cells, ! nonIirradiated! NOD/SCID/ILI2rγnull ! (NSG)! mice! (The!Jackson! Laboratory,! Bar! Harbor,! ME)! were! injected! via! tail ! vein! with!1x106! GFP! positive! NALM6! wild! type! or! GFP! positive! NALM6! CXCR4!Knock! out! cells. ! Bioluminescence! imaging! (BLI)! was! performed! on! days!6, ! 10,! 14! and! 17! to! evaluate! tumor! burden.! Briefly, ! mice! were!anesthetized! and! imaged! noninvasively! with! an! in! vivo! imaging! system!(IVISI200;! Xenogen,! Hopkinton,! MA)! after! injection! with! luciferase!
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substrate! coelenterazine! (Biotium,! Heyward,! CA). ! Total! body!bioluminescence! was! quantified! in! a! region! of! interest! drawn! around!each!mouse.! Three!mice! per! group!were! sacrificed! on!day! 17! to!measure!GFP! positive! leukemic! cells! in! different! organs! and! femurs.! The!expression!of!surface!CXCR4!protein!was!analyzed!by!using!a!Gallios!flow!cytometer!(Beckman!Coulter, !Brea,!CA), !and!harvested!cells!were!stained!with! antibodies! against! CXCR4Iallophycocyanin! (12G5).! Overall ! survival!and! mean! group! survival! times! were! estimated! by! the! KaplanIMeier!method!and!compared!with!the!logIrank!test. !!
Data!Analysis!and!Statistics!Results! have! depicted! as! mean! ±! standard! error! about! the! mean!(SEM),! of! at! least! three! experiments! each.! PEP! were! conducted! twice! in!duplicates. ! Statistical! analysis! was! done! with! GraphPad! Prism! 6.0! for!Macintosh! (GraphPad! Software,! San! Diego,! CA,! USA). ! TwoItailed!students’ ! tItest! was! used! for! statistical! comparison! between! groups! and!the! P ! values! were! assigned! as! follows! (*P ! <! 0.05;" **P" <" 0.01;! ***P" <!0.001). ! Flow! Cytometry! data! were! analyzed! using! FLOWJO! 9.4.11!software!(TreeStar!Inc.). !!
Patient!data!set!analysis!Patient! characteristics! are! summarized! in! Table! S1.! CXCR4! and! CD49D!surface! levels! on! BIALL! cells!were! quantified! by! flow! cytometry! in! bone!
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Figure! 9. ! BRALL! cell! lines! display! variable! expression! of! adhesion!
































































Figure! 11. ! Xenograft! expanded! primary! BRALL! cells! display! variable!




























Figure! 12. ! Comparison! of! CXCR4! and! CD49D! expression! in! cell! lines!
























Figure! 13.! CXCR4! is! downRregulated! after! coRculture! with! BMSC.!Histograms! depict! CXCR4! expression! of! BIALL! cells! in! the! presence! or!absence!of!BMSC!(OP9!or!9I15C!cells)!after!48!hours. !Compared!to!BIALL!cells! alone! (blue! lines), ! coIculture!with!BMSC! (green! lines)! resulted! in! a!substantial! downIregulation! of! surface! CXCR4,! due! to! CXCL12Iinduced!receptor!internalization.!! !
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Xenograft!expanded!BIALL!cells!displayed!drastically! lower!CXCR4! levels!than! cell ! l ines. ! This! could! be! possible! due! to! continuous! internalization!of! CXCR4! because! xenograft! expanded! primary! cells! are! routinely! coIcultured!with!OP9!bone!marrow!stromal! cells! that! constitutively!express!CXCL12.! To! test! this! hypothesis! xenograft! expanded! primary! cells! were!cultured! without! stromal! cells! for! 48! hours! and! then! CXCR4! expression!quantified.! Indeed,! the! CXCR4! levels! increased! upon! culturing! the! cells!alone.! To! confirm! these! results, ! BIALL! cell ! l ines!were! cultured!with! and!without! stromal! cells. ! As! expected,! CXCR4! levels! on! BIALL! cell ! l ines!decreased! considerably! upon! exposure! to! bone! marrow! stromal! cells!corroborating!the!internalization!hypothesis!(Figure!13). !!
CXCR4!antagonists!inhibit!BRALL!cell!migration!and!adhesion!
! Chemotaxis! of! ALL! cell ! l ines! and! xenograft! cells! towards! CXCL12!chemokine! was! tested! by! the! transIwell ! assay! as! previously!explained(67). ! The! concentration! of! CXCL12! to! be! used! for! chemotaxis!experiments!was! determined! through! a! CXCL12!dose! titration! using!REH!cell ! l ine. ! The! doses! used!were! 50,! 100,! 200,! 400! and! 100! ng/mL! (Figure!14). ! A! dose! of! 100ng/mL! was! found! to! be! optimal! for! BIALL! cell ! l ines. !PreIincubation! with! 10μg/mL! Plerixafor! or! BKT140! for! oneIhour!abrogated! chemotaxis! to! CXCR4! ligand! CXCL12! (100ng/ml)! in! all ! cell !l ines! and! xenograft! expanded! primary! cells! tested! (Figure! 15! and! 16). !For! example,! preItreatment! of! NALM6! cell ! l ine! with! Plerixafor! and!
! ~!61!~!



























Figure! 14. ! Determination! of! optimum! CXCL12! dose! for! BRALL!


































































Figure! 15.! CXCR4! inhibitors! plerixafor! (AMD3100)! and! BKT140!













































Figure! 16.! CXCR4! inhibitors! plerixafor! (AMD3100)! and! BKT140!
significantly! reduce! chemotaxis! of! xenograft! expanded! BRALL! cells. !Xenograft! expanded! BIALL! cells! were! incubated! in! medium! alone!(control)! or! medium! containing! (10μg/ml)! plerixafor! (AMD3100)! or!BKT140.! The! cells! were! allowed! to! undergo! chemotaxis! towards! 100!ng/mL! CXCL12! and! then! counted! in! flow! cytometer! for! quantification.!The! bar! diagrams! represent! the! mean! chemotaxis! (±! SEM)! of! 3! BIALL!xenografts! in! the! presence! or! absence! of! CXCR4! inhibitors. ! Chemotaxis!was! significantly! inhibited! by! both! CXCR4! inhibitors!(plerixafor/BKT140),!with!*p !<!0.05;"**p"<"0.01;!***p"<!0.001!as! indicated!by!the!asterisks. !! !
! ~!68!~!
As! mentioned! previously, ! ALL! cells! undergo! a! CXCR4! mediated! in!vitro! process! called! Pseudoemperipolesis! (PEP)! to! migrate! under!stromal! cells. !Figure!17!shows!representative!phase!contrast!microscopy!images! of! BIALL! cell ! l ines! and! SFO3! xenograft! expanded! primary! cells!undergoing! PEP! beneath! 9I15C! stromal! cells. ! Cells! that! migrated! below!the!mesenchymal!marrow!stromal!cell ! l ine! (9I15C)!were!counted!by! flow!cytometry! as! previously! explained(67). ! Significant! inhibition! of! ALL! cell !migration! under! BMSCs! was! observed! (Figure! 18! &! 19)! for! all ! cell ! l ines!and! xenograft! expanded! primary! cells! tested! in! response! to! preIincubation! with! 10μg/ml! plerixafor! and! BKT140.! For! example, ! NALM6!cell ! l ine! PEP! was! significantly! reduced! upon! preItreatment! with!10μg/mL!plerixafor!or!BKT140! to!61.4!±!10.8%!and!35.5!±!5.5%!(mean!±!SEM,! p<0.05)! respectively! as! compared! to! control! untreated! cells. !Similarly, ! SFO3! xenograft! cell ! PEP! was! significantly! decreased! upon!10μg/mL!plerixafor!or!BKT140! to!53.2!±!4.08%!and!53.8!±!6.5%!(mean!±!SEM,!p<0.05)!respectively!as!compared!to!control!untreated!cells. !
! ~!69!~!
! ! ! ! ! ! ! !
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Figure! 17. ! CXCR4! inhibitors! plerixafor! (AMD3100)! and! BKT140!


































































Figure! 18.! CXCR4! inhibitors! plerixafor! (AMD3100)! and! BKT140!
















































Figure! 19.! CXCR4! inhibitors! plerixafor! (AMD3100)! and! BKT140!
significantly! reduce! Pseudoemperipolesis! of! xenograft! expanded!
















































Figure! 20.! Combination! treatment! with! CXCR4! and! CD49d!
antagonists! inhibits! BRALL! cell! migration! beneath! BMSC! (PEP)!more!
effectively! than! single! inhibitor! treatment.! NALM6! BIALL! cells! were!incubated! in! medium! alone! (control), ! or! medium! supplemented! with!plerixafor! (10μg/mL),! BKT140! (10μg/mL),! CS1! (10μg/mL),! or!combinations! of! CSI1! with! either! CXCR4! antagonist, ! and! then! placed! in!BMSC! coIcultures. ! After! 4! hours! of! incubation,! and! then! counted! in! flow!cytometer! for! quantification.! The! bar! diagram! represents! the! mean! PEP!(±!SEM)! (Plerixafor/BKT140),!with! *p!<!0.05;! **p!<!0.01;! ***p!<!0.001!as!indicated!by!the!asterisks. !!!!!!!!!!!!!!
! ~!77!~!
!! The!bone!marrow!microenvironment! is!a!complex!milieu!of!various!cell ! types!and!secreted!or!surfaceIbound! factors. ! In! this!dynamic!setting,!various! molecules, ! apart! from! CXCR4,! are! involved! in! the! processes! of!adhesion! and! migration.! CD49D! has! been! implicated! in! adhesion! of! ALL!cells! in! various! previous! studies. ! BIALL! cells! showed! reduced! levels! of!migration! beneath! stromal! cells! when! treated! with! CD49D! levels. !Interestingly, ! the! combination! of! CXCR4! and! CD49D! further! significantly!reduced! migration! of! NALM6! and! RS4.11! cells! beneath! bone! marrow!stromal!cells!(Figure!20). !
CXCR4!Knock!out!inhibits!adhesion!and!migration!of!ALL!cells!









Figure! 21. ! The! CRISPRRCas9! gene! editing! technology ! (68). ! The!CRISPRICas9! system! functions! as! a! part! of! defense! system! against!invading! DNA! molecules! for! example! viruses. ! The! Cas9! enzyme! is! DNA!endonuclease!with!two!active!sites!that!cleave!the!two!strands!of!doubleIstranded! DNA.! The! Cas9! enzyme! is! guided! towards! the! target! genomic!site! by! an! RNA!molecule! that! is! complementary! to! the! target! site, ! which!is! demarcated! by! the! Protospacer! Adjacent! Motif! (PAM)! sequence.!Consequently, ! the! CRISPRICas9! system! induces! siteIspecific! double!stranded! DNA! breaks,! which! are! repaired! by! the! cells! endogenous! nonIhomologous!end!joining!or!homologous!recombination.!
Adapted!with!permission!from!






Table!1. !Different!parameters!used! to!determine! the! ideal! conditions! for!BIALL!cell !electroporation.!
Well$ Voltage$(V)$ Width$(mill isecond)$ Pulse$
1$ 0! 1! 1!
2$ 1400! 20! 1!
3$ 1500! 20! 1!
4$ 1600! 20! 1!
5$ 1700! 20! 1!
6$ 110! 30! 1!
7$ 1200! 30! 1!
8$ 1300! 30! 1!
9$ 1400! 30! 1!
10$ 1000! 40! 1!
11$ 1100! 40! 1!
12$ 1200! 40! 1!
13$ 1100! 20! 2!
14$ 1200! 20! 3!
15$ 1200! 20! 4!
16$ 1400! 20! 2!
17$ 850! 30! 2!
18$ 950! 30! 2!
19$ 1050! 30! 2!
20$ 1150! 30! 2!
21$ 1300! 10! 3!
22$ 1400! 10! 3!
23$ 1500! 10! 3!
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Figure! 22. ! CXCR4! deletion! from! BRALL! using! the! CRISPRRCas9! gene!
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Figure! 24.! CXCR4! gene! deletion! significantly! decreases! chemotaxis!














































































Figure! 25.! Growth! rate! comparison! of! wild! type! vs.! knockout! BRALL!




CXCL12! was! first! discovered! as! a! PreIBICell ! growthIstimulating!factor(69). ! To! determine! the! effect! of! CXCR4! knockout! on! BIALL! cell !l ines, ! we! conducted! a! growth! assay! comparing! the! growth! rates! of! wild!type!vs. ! knockout! cell ! l ines. ! Figure!25! shows! results! from! three! separate!experiments. !No!significant!difference! in!growth!rates!between!wild!type!and! knockout! cell ! l ines! was! observed! indicating! that! malignant! cells, ! at!least! the! ones! in! culture, ! have! adapted! themselves! to! overcome! CXCR4!dependent!proliferation.!
Bone! marrow! Stromal! Cells! provide! CellRAdhesion! Mediated! Drug!
Resistance!to!BRALL!Cells!

































































































































































Figure! 26.! Dose! determination! of! 4RHydroperoxy! Cyclophosphamide!
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Figure! 28. ! Dose! determination! of! Vincristine! (Vin)! in! BRALL! cell!






Control' 2nM' 3nM' 5nM' 10nM'




Figure! 29. ! Effect! of! chemotherapy! drugs! on! BMSCs . ! Phase! contrast!microscopy! images! represent! growth! of! 9I15C! murine! BMSC! cell ! l ine!after!48!hours!of! treatment!with!difference!concentrations!of!Vincristine!and!Dexamethasone.! !
! !
! ~!99!~!
To! determine! whether! the! chemotherapeutic! drugs! have! any!adverse!effects!on!the!bone!marrow!stromal!cells!being!used,!the!stromal!cell ! l ine! was! treated! with! indicated! concentrations! of! Dexamethasone!and! Vincristine! before! conducting! chemoIsensitization! assays. ! As! stated!earlier, ! the! concentration! range! of! Vincristine! for! BIALL! cell ! l ines! is! 2I3!nM! and! 50I100! nM! for! Dexamethasone.! It ! was! observed! that! IC50!concentrations! for! both! drugs! for! BIALL! cells! did! not! affect! the! 9I15C!cell ! l ine. ! Vincristine! did, ! however! have! an! effect! at! concentrations! of!5nM!and!above.!
4IHydroperoxy! Cyclophosphamide! (4HC)! was! not! tested! on! the!stromal! cells! because! 4HC! treatment! includes! incubation! of! BIALL! cells!for! 45! minutes! and! then! change! of! media. ! Due! to! this! the! stromal! cells!are!not!exposed!to!the!drug. !
To! determine! the! effect! of! chemotherapeutic! drugs! on! the! BIALL!cells! that! had! undergone! PEP,! we! measured! viability! of! a! drug! treated!coIculture! well . ! The! well ! was! thoroughly! washed! and! supernatant!discarded.! The! stromal! layer! with! the! migrated! BIALL! cells! was! then!trypsinized! and! viability! measured! using! PI/DiOC6! staining.! Figure! 29!depicts! the! gating! strategy! for! this! experiment. ! Briefly, ! a!well !with! drug!treated!BIALL!cell ! l ine!alone!was!taken!as!a!gating!template!and!all !cells, !alive! and! apoptotic, ! were! gated! around! to! get! a! lymphocyte! gate. ! This!gate!was! then! applied! to! the! drug! treated! coIculture. ! Since! stromal! cells!
! ~!100!~!















































































Figure! 30. ! Gating! strategy! for! viability! measurement! of! BRALL! cells!














































































Figure! 31.! Bone! Marrow! Stromal! Cell! (BMSC)! coRculture! overcomes!
drugRinduced! cytotoxicity! of! BRALL! cell! line. ! (A)! Dot! plots! show!representative! experiment! depicting! viability! of! drug! (Dex)! treated!NALM6! cells! in! the! presence! and! absence! of! BMSC! coIculture. ! In! the!NALM6IBMSC! coIculture! sample, ! viability! of! NALM6! cells! in! supernatant!and! those! that! migrated! beneath! the! stroma! was! measured! separately. !(B)! Bar! graphs! show! mean! of! three! separate! experiments! il lustrated! in!contour! plots! (A). ! In! addition! to! Dex! treatment! (leftIhand! graph), ! the!experiment! was! also! performed! with! 2.5µM! 4IHydroperoxyCyclophosphamide! (4HC)! and! Vincristine! in! the! presence!and! absence! (control)! of! BMSC! coIculture. ! Bar! diagrams! represent!mean!drug! induced! cytotoxicity! (±! SEM)! of! three! separate! experiments. !Viability! was! measured! using! PI/DiOC6! staining! at! 48H! and! asterisks!indicate!significant!differences!in!cytotoxicity!(*p !<!0.05;"**p"<"0.01). !! !
! ~!105!~!
To! test! the! effect! of! Bone! Marrow! Stromal! Cells! on! drug! induced!cytotoxicity, ! NALM6! cells! were! treated! with! Dexamethasone! (Dex), ! 4IHydroperoxyCyclophosphamide! (4HC),! Vincristine! (Vin)! with! and!without! coIculture! with! 9I15C! stromal! cell ! l ine! and! viability! measured!using!PI/DiOC6.! Figure!30! shows! representative!dot! plots! of!Dex! treated!NALM6! cells! in! the! presence! and! absence! of! 9I15C! stromal! cell ! l ine. ! CoIculture! of! NALM6! cells! with! mesenchymal! marrow! stromal! cell ! l ine! (9I15C)! significantly! increased! viability! to! 70.3! ±! 1.04%! as! compared! to!57.6! ±! 1.08%! from! treatment! with! Dex! alone! (mean! ±! SEM,! p<0.05). !Similarly, ! mesenchymal! marrow! stromal! cell ! l ine! (9I15C)! significantly!increased! viability! of! NALM6! to! 63! ±! 4.1%! as! compared! to! 44.9! ±! 4.8%!from! treatment! with! Vin! alone! (mean! ±! SEM,! p<0.05). ! A! similar! trend!was! observed! with! 4HC! treatment! where! the! viability! for! NALM6! cells!with! 4HC! treatment! alone!was! 72.5! ±! 4.46%! and!was! increased! to! 81.67!±!3.45%!with!BMSC!coIculture!(mean!±!SEM,!p=not!significant). !However, !only! a!modest! rescue!was! observed! in! the! supernatant! of! the! coIculture. !As! stated! earlier, ! BIALL! cells! undergo! Pseudoemperipolesis! and! reside!under! BMSCs,! to! analyze! drug! induced! cytotoxicity! in! those! cells! the!BMSC! layer! was! trypsinized! and! viability! measured! (gating! strategy!depicted! in! Figure! 29). ! Cells! that! had! undergone! PEP! and! were! beneath!the!stromal!cells!were!highly!resistant! to!Dex,!4HC!and!Vin!with!viability!of! 93.7! ±! 1.9%,! 94.9! ±! 2.3%,! 93.4! ±! 0.5%! (mean! ±! SEM,! p<0.05)!
! ~!106!~!
respectively! as! compared! to! the! NALM6! cells! in! the! supernatant! (Figure!30). ! !
CXCR4! inhibition! or! deletion! overcomes! BMSC! derived! drug!
resistance!
To! test! the! effect! of! inhibition! of! chemokine! receptor! CXCR4! on!BMSC! derived! chemotherapy! resistance,! NALM6! cells! were! preItreated!with, ! 10µg/ml! Plerixafor! or! 10µg/ml! BKT140! before! Dex,! 4HC! or! Vin!drug!treatment. !The!addition!of!Plerixafor!or!BKT140!to! the!DexINALM6IBMSC! coIculture! significantly! decreased! the! viability! of! NALM6! cells! to!57.9! ±! 3.2%! and! 54.2! ±! 3.2%! respectively! as! compared! to! the! DexINALM6IBMSC! coIculture! alone! (72.38! ±! 0.25%,! mean! ±! SEM,! p<0.05)!(Figure! 4A). ! Similarly, ! Plerixafor/BKT140! addition! to! the! VinINALM6IBMSC!coIculture! sensitized!cells! to!Vin! treatment! increasing! cytotoxicity!to!33.8!±!2.08%!and!33.5!±!3.1%!viable!cells! respectively!as!compared! to!VinINALM6IBMSC! alone! (58.5! ±! 1.6%,! mean! ±! SEM,! p<0.05). ! Lastly, !Plerixafor/BKT140! addition! to! the! 4HCINALM6IBMSC! coIculture!increased! cytotoxicity! to! 66.03! ±! 5.1%! and! 67.1! ±! 1.2%! viable! cells!respectively!as!compared! to!4HCINALM6IBMSC!alone!(82.9!±!1%,!mean!±!SEM,!p<0.05)! (Figure!4A). !This! reversal!of! acquired! resistance!of!NALM6!after! the! addition! of! CXCR4! inhibitors! outlines! the! critical! role! that!CXCR4! plays! in! making! the! cells! resistant! to! chemotherapy.! Similar!
! ~!107!~!
results! obtained! with! Dex! treated! ICN12! xenograft! and! REH! and! Z119!cell ! l ines!indicating!that!this!is!not!a!cell ! l ine!phenomenon!(Figure!31). ! !
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Figure! 33.! CXCR4! deletion! abolishes! BMSC! derived! rescue! of! drug!
treated! NALM6! cells . ! NALM6! CXCR4! Wild! type! (WT)! (black! bars)! and!NALM6!CXCR4!Knockout! (KO)! (grey! bars)!were! treated!with! 100! nM!Dex!(left!hand!side!graph)!or!2nM!Vin!(right!hand!side!graph)!in!the!presence!and! absence! (control)! of! BMSC! coIculture! and! viability! measured! for!cells! in! the! supernatant. ! Bar! diagrams! representing! mean!chemotaxis/PEP! (±! SEM)! show! significant! inhibition! by! both! CXCR4!inhibitors! (Plerixafor/BKT140),! with! *p!<!0.05%&**p&<&0.01'!***p&<!0.001 !as!indicated!by!the!asterisks. !! !
! ~!112!~!
To! further! corroborate! the! findings! of! pharmacological! inhibition!of! CXCR4! in! the! coIculture! setting,! NALM6! CXC4! KO! cells! were! treated!with! Dexamethasone! and! Vincristine! in! the! presence! and! absence! of!BMSCs! (Figure! 32). ! Unlike! wild! type! NALM6! cells, ! Dex! or! Vin! treated!NALM6! CXCR4! KO! cell ! l ine! showed! no! significant! difference! in!cytotoxicity! in! the! absence!or!presence!of!BMSCs! (57.5!±!3.8%!vs. ! 52.8!±!5.2%! for! Dex! and! 53.5! ±! 5.5%! vs. ! 60.06! ±! 2.9%! for! Vin,! respectively, !mean! ±! SEM,! p=not! significant). ! The! failure! of! BMSCs! to! rescue! NALM6!CXCR4! KO! from! Dex! induced! cytotoxicity! indicates! the! importance! of!CXCR4!in!acquired!chemoIresistance.!
CXCR4! deletion! decreases! leukemia! burden,! bone! marrow!
infiltration!and!increases!survival!in!leukemic!mice!
To! test! the! effect! of! CXCR4! deletion! in! vivo,! nine! nonIirradiated!NSG! mice! per! group! were! injected! with! GFP! positive! NALM6! WT! or!NALM6! CXCR4! KO! cells! and! bioluminescent! Intensity! (BLI)! measured! at!day! 6, ! 10,! 14! and! 17! (Figure! 33). ! Mice! injected! with! NALM6! CXCR4! KO!had! significantly! less! BLI! signal! than! NALM6!WT! throughout! the! course!of! the! disease! (p<0.001! on! day! 6, ! p<0.05! on! day! 10,! p<0.05! on! day! 14,!and! p<0.001! on! day! 17). ! In! three! representative! mice! per! group!sacrificed! on! day! 17,! flow! cytometry! demonstrated! that! mice! injected!with! NALM6! CXCR4! KO! cells! had! less! leukemic! infiltration! in! bone!marrow! than! NALM6! WT! (mean! ±! SEM,! 30.3%! ±! 4.4%! vs. ! 2.8%! ±! 1.4%,!
! ~!113!~!











Figure! 34.! Bioluminescent! intensity! of! mice! injected! with! GFP!















Figure! 35. ! CXCR4! deletion! reduces! bone! marrow! infiltration! of!
















Figure! 36. ! CXCR4! deletion! decreases! blood! counts! of! leukemic! cells!

















Figure! 37.! Leukemic! cell! count! of! the! spleen! of! mice! injected! with!










Figure! 38. ! CXCR4! deletion! significantly! decreases! disease! burden! in#









Figure! 39.! CXCR4! Knockout! cells!maintain! lack! of! CXCR4! expression!













Figure! 40. ! CXCR4! deletion! significantly! increases! survival! of! BRALL!













CXCR4! expression! does! not! correlate! with! overall! and! relapse! free!
survival!in!PreRBRALL!patients!





































Table! 3. ! Univariate! Cox! proportional! hazards! models! for! Overall !Survival!
!
!!!!!!!!!!!!!!!!!!!!!
covariate HR 95% CI p-value N_dead N_total 
Age_at_Start 1.00 0.99 1.02 0.60 39 137 
log(CD49) 0.97 0.71 1.33 0.85 35 120 
log(CXCR4) 1.04 0.84 1.30 0.71 35 120 
log(WBC) 1.00 0.83 1.20 0.99 39 135 
BM_blast 1.02 1.00 1.05 0.03 39 134 
log(PB blast) 0.97 0.80 1.17 0.73 37 131 
Hgb 0.91 0.75 1.11 0.36 38 132 
log(PLT) 0.69 0.50 0.97 0.03 38 132 
LDH 1.00 1.00 1.00 0.51 36 128 









Variable HR 95% CI p-value 
BM_Blast 1.02 1.00 1.05 0.05 
Alb 0.35 0.16 0.73 0.01 
log(CXCR4) 0.85 0.66 1.08 0.18 
log(CD49) 0.88 0.59 1.31 0.52 
 
! ~!132!~!
Table! 5. ! Univariate! cox! proportional! hazards! model! for! relapseIfree!survival!among!129!patients!who!have!achieved!CR,!CRp!or!PR!
! !
! !
covariate HR 95% CI p-value Event Total 
Age_at_Start 1.00 0.98 1.01 0.68 40 129 
log(CD49) 1.22 0.89 1.67 0.22 36 112 
log(CXCR4) 1.13 0.92 1.39 0.25 36 112 
log(WBC) 1.08 0.91 1.28 0.40 40 127 
BM_blast 1.02 1.00 1.04 0.03 40 126 
log(PB blast) 1.03 0.85 1.25 0.74 39 124 
Hgb 0.95 0.77 1.16 0.61 39 124 
log(PLT) 0.72 0.51 1.01 0.06 39 124 
LDH 1.00 1.00 1.00 0.57 37 120 








Table! 6. ! Multivariable! cox! proportional! hazards! model! for! CR! duration!among!patients!who!have!achieved!CR,!CRp!or!PR!(N=110,!N_event=36)!
!
! !
Variable HR 95% CI P-value 
BM_Blast 1.02 1.00 1.05 0.08 
log(CXCR4) 1.03 0.83 1.28 0.79 







Variable( Odds(Ratio( 95%(CI( P5value(
Age_at_Start 0.98% 0.94% 1.02% 0.29%
log(CD49) 1.24% 0.72% 2.13% 0.44%
log(CXCR4) 1.22% 0.80% 1.87% 0.35%
log(WBC) 1.10% 0.72% 1.66% 0.67%
BM_blast 1.00% 0.96% 1.04% 0.92%
log(PB blast) 1.10% 0.70% 1.71% 0.69%
Hgb 1.10% 0.68% 1.79% 0.70%
log(PLT) 1.40% 0.68% 2.90% 0.36%
LDH 1.00% 1.00% 1.00% 0.50%
Alb 2.09% 0.48% 9.10% 0.33%








































The! clinical! significance! of! inhibition! of! the! CXCL12/CXCR4!pathway! spans! various! diseases! including! metastasis(70), ! arthritis(71), !WHIM!syndrome(72), !HIV!entry!to!CD4!positive!TICells(73)!and!leukemia!migration! and! dissemination.! Highly! specific! inhibitors! of! this! pathway!were! first! developed! to! inhibit! HIV! entry! into! CD4! positive! T! cells(64,!74,! 75). ! High! levels! of! CXCR4! surface! expression! have! been! associated!with!inferior!prognosis! in!ALL!patients(57,!59)!and!in!our!study!we!show!evidence! that! CXCR4! could! serve! as! an! effective! target! worth! exploring!in! BICell ! Acute! Lymphoblastic! Leukemia.! It ! has! been! previously!demonstrated! that! Bone! Marrow! Stromal! Cells! protect! leukemia! cells!from! chemotherapy!using! various! secreted! and! surface! bound! factors. ! In!this! study,!we! demonstrate! that! CXCR4! is! one! of! the! central!mechanisms!used!by!stromal!cells!to!provide!chemoIresistance!to!BIALL!cells. ! !
We! observed! that! all ! BIALL! cell ! l ines! and! xenografts! tested!positive! for!CXCR4! irrespective!of! their!maturation!stage.!The!absence!of!other! chemokine! receptors! indicates! that! CXCR4! is! possibly! one! of! the!most! important! chemokine! receptor! present! in! BIALL! cells. ! This! is! also!corroborated! by! the! lethal! phenotype! of! both! CXCR4! and! SDF1! deficient!mice!showing!defective!BICell !development. !Xenografts!showed!markedly!lower! CXCR4! expression! than! cell ! l ines! but! the! presence! and! activity! of!CXCR4! was! evidenced! by! the! functional! responses! to! CXCR4! activation!and! inhibition! stimuli . ! The! xenograft! cells! displayed! significant!chemotaxis! and! extensive! PEP! beneath! BMSCs! and! these! responses!were!
! ~!141!~!
significantly! decreased! upon! CXCR4! inhibition.! The! low! CXCR4! surface!expression!was!possibly!due!to!coIculture!conditions!in!which!xenografts!are! routinely! maintained.! Upon! CXCL12! binding,! CXCR4! has! been!reported! to! undergo! endocytosis! and! internalization! to! vesicles! from!where! it ! is! recycled! to! the! cell ! surface. ! Constitutive! secretion! of! CXCL12!by! the! stromal! cell ! layer! might! cause! internalization! of! the! CXCR4!receptor! thereby! reducing! surface! expression.! Indeed,! when! xenograft!cells!were! taken! off! stroma,! CXCR4! expression! increased! as! compared! to!the! coIculture! setting. ! Similar! observations! were!made! by! Van! den! Berk!et! al ! (59)! in! BIALL! patients, ! they! showed! significantly! lower! CXCR4!expression! in! leukemic! bone! marrow! cells! than! of! the! peripheral! blood.!This! possibly! serves! the! purpose! of! homeostatic! regulation,! where!CXCR4! expression! is! down! regulated! in! BM! and! upIregulated! in!peripheral! blood! to! maintain! equilibrium! between! BM! homing! and!egress. ! Lai! et! al ! (76)! reported! that! sustained! CXCR4! signaling!enhancement! in! vivo! resulted! in! diminished! peripheral! blood!reconstitution,! l ikely! due! to! the! prevention! of! release! of! hematopoietic!cells! from! the! bone! marrow(76). ! This! phenomenon! could! also! explain!high! levels!of!CXCR4! in!cell ! l ines, ! since! they!are!continuously!cultured! in!the! absence! of! stromal! cells. ! Indeed,! BIALL! cell ! l ines! displayed! lower!CXCR4! levels! upon! BMSC! coIculture! exposure.! An! additional! chemokine!receptor! of! interest! was! the! second! CXCL12! receptor! CXCR7,! which! has!been! previously! known! to! be! a! decoy! receptor! acting! as! a! sink! for!
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CXCL12(77). !However, !all ! cell ! l ines! tested!negative! for!CXCR7,! ruling!out!any!involvement!in!BIALL!pathogenesis. !
It ! has! been! shown! in! previous! studies! that! in! human! BIcells!derived! from! bone! marrow! that! CXCR4! expression! level! does! not!correlate! with! responsiveness! to! CXCL12(78). ! As! mentioned! above,! the!internalization! of! CXCR4! is! the!major! factor! in! play. ! Indeed,! Tarasova! et!al ! demonstrated! that! CXCR4! undergoes! spontaneous! ligand! independent!internalization! and! gets! sorted! into! endosomes(79). ! Additionally, ! it ! has!been! demonstrated! that! in! leukocytes! the! internalization! and! recycling!of! CXCR4! is! a! rapid! process! that! takes! place! in! response! to! various!stimuli . ! Additionally, ! B! cells! have! a! large! intracellular! pool! of!CXCR4(80). ! Considering! the! above! information,! it ! is! clear! that!quantification! of! CXCR4! surface! expression! at! a! singular! time!point! does!not! represent! the! entirety! of! functional! CXCR4! present! in! the! cell ! which!is! possibly! why! the! surface! expression! on! cells! does! not! correlate! with!functional!responses!like!chemotaxis!and!pseudoemperipolesis. !
CXCR4! inhibitor! preItreatment! significantly! reduced! chemotaxis! to!CXCL12! and! PEP! under! BMSCs! for! all ! xenografts! and! cell ! l ines! tested.! It !was! observed! that! exposure! to! CXCR4! inhibitors! induced! a! more! robust!decrease! in! chemotaxis! than! in! PEP.! The! chemotaxis! assay! is! conducted!in! Transwell! chambers! with! only! CXCL12! in! the! lower! chamber! and!blockade! of! CXCR4! disrupts! this! linear! interaction.! Essentially, ! in! our!
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setting,! the! chemotaxis! assay! is! a! quantification! of! the!movement! of! the!cells! in!response!to!a!single!chemokine!attractant. !On!the!other!hand,!the!PEP! coIculture! is! a! dynamic! setting! with! several! factors! other! than!CXCR4! involved.! Indeed,! in! addition! to! migration,! adhesion! processes!start! to! play! a! role! in! the! coIculture! and! although! CXCR4! is! possibly! the!main! chemotactic! factor! for!BIALL,! several! other! adhesion!molecules! are!expressed! by! them.! One! such! factor! is! CD49D! (or! VLAI4)(28)! and! it ! was!observed! in! our! experiments! that! a! combination! of! CXCR4! and! CD49D!inhibitors! significantly! decreased! PEP! as! compared! to! CXCR4! or! CD49D!inhibitors!alone.!
Besides! inhibition! of! CXCR4! function,! CXCR4! antagonists! also! can!induce!signaling!after!binding!to!its!target, !CXCR4.!Plerixafor!and!ALX40I4C! have! been! characterized! as! weak! partial! agonist, ! whereas! the!polyphemusin! derivative! peptide! inhibitor! BTK140!was! characterized! as!an! inverse! CXCR4! agonist(81). ! Signaling! responses! induced! by!stimulation! of! CXCR4!with! high! concentrations! of! plerixafor! and! ALX40I4C!were! less! robust! than! those! seen!with! its!natural! ligand,!CXCL12,! and!hence!plerixafor!and!ALX40I4C!were!characterized!as!peak!partial!CXCR4!agonist(81). ! The! agonistic! activity! of! plerixafor! and! ALX40I4C! raise!concern! that! some! of! the! activity! seen! with! CXCR4! antagonists! may! be!due! to! agonistic! activity, ! rather! than! blockade! of! CXCR4! function.! Along!the! same! lines, ! preclinical! work! with! BMSI936564/MDXI1338,! a!therapeutic! antiIhuman! CXCR4! monoclonal! antibody,! revealed! that! this!
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CXCR4! antagonist! also! induced! downstream! signaling. ! The! authors!compared! BMSI936564! with! plerixafor! in! preclinical! assays! and! noted!marked! differences;! while! BMSI936564! induced! target! cell ! apoptosis, !plerixafor! did! not, ! suggesting! that! antibody! binding! to! CXCR4! drives! a!signal! to! induce!apoptosis! that! is! independent! from! inhibition!of!CXCL12!binding(82). ! These! differences! in! inhibitorIinduced! signaling! raise! the!question! whether! some! of! the! antiIleukemia! activity! seen! in! prior!studies! may! be! related! agonistic! activity! of! the! CXCR4! antagonist. !Therefore, ! we! compared! pharmacologic! and! genetic! functional! deletion!of!CXCR4!in!preclinical!models!of!BIALL.!
It ! has! been! previously! shown! that! the! microenvironment! protects!leukemia! cells! from! drugIinduced! cytotoxicity. ! More! importantly, ! we!analyzed! the! cells! that! had! undergone! PEP! to! reside! under! the! stromal!cell ! layer, !mimicking! leukemia! cells! in! the! bone!marrow.!The! viability! of!these! cells!was!unaffected!by!drug! treatment! and! similar! to! control! cells!without! any! drug,! revealing! the! high! degree! of! chemoIprotection! stroma!provides!to! leukemia!cells. !This!observation!highlights! the! importance!of!new! therapeutic! agents! that! not! only! inhibit! cells! from! homing! to! the!bone!marrow,!but! also!promote! egress!of! leukemia! cells! already! in! these!niches. ! This! has! been! evidenced! by! the! fact! that! Plerixafor! has! already!been! approved! as! a! stem! cell ! mobilizer! in! NonIhodgkins! lymphoma! and!multiple!myeloma(60). !
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In! addition! to! being! an! effective! mobilizer! of! CXCR4! positive! cells!from! bone! marrow! niches, ! CXCR4! antagonists! have! also! been! shown! to!sensitize! leukemia! cells! to! conventional! chemotherapy! in! CLL(83)! and!AML(84). !Our! experiments!demonstrate! that!CXCR4! is! an!effective! target!in! ALL! as! well . ! Plerixafor! and! BKT140! sensitized! ALL! cell ! l ines! to!cytotoxicity! induced! by! Dexamethasone,! Vincristine! and!Cyclophosphamide.! The! addition! of! CXCR4! inhibitors! to! conventional!chemotherapy! thus! becomes! a! dual! treatment! strategy! wherein! CXCR4!inhibition! not! only! drives! leukemia! cells! out! of! their! protective! niches!but!also!makes!cells!more!sensitive!to!chemotherapy!treatment. !
To! corroborate! our! findings! in! the! pharmacological! inhibition! of!CXCR4! we! generated! a! CXCR4! genetic! deletion! model! and! observed! the!similar! deficient! chemotaxis! and! PEP.! CXCR4! knockout! BIALL! cells!displayed!no!difference! in! the!growth!rates!as!compared! to! the!wild! type!cells! even! though! CXCL12! was! first! identified! as! a! preIBIcell ! growth!stimulating! factor. ! This! indicates! to! the!possibility! that!BIALL! cells! have!potentially! gained! independence! from! CXCR4! signaling! for! their!proliferation.! Additionally, ! CXCR4! knockout! cells!were! not! rescued! from!drugIinduced! cytotoxicity! by! stromal! cell ! coIculture! like! the! CXCR4!wild!type!counterparts! indicating!the!essential!role!of!the!CXCL12/CXCR4!axis!in! chemoIresistance! of! BIALL! cells. ! This! also! indicates! that! BIALL! cells!depend! on! CXCR4! for! their! survival! but! not! proliferation.! This! also!corroborates! with! the! fact! that! CXCR4! knockout! cell ! l ines! maintain!
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CXCR4! negative! status! in! spite! of! longIterm! culture. ! If ! CXCR4! positive!cell ! l ines! had! a! proliferative! edge! as! compared! to! wild! type! cells, ! the!miniscule! number! of! CXCR4! positive! cells!would! potentially! outgrow! the!knockout! cells! over! times.! This! was! also! observed! in! our! in" vivo !experiments! where! mice! injected! with! knockout! cells, ! showed! CXCR4!negative!cells!throughout!the!course!of!the!experiment. !
To! understand! the! role! CXCR4! plays! in! BIALL! engraftment, !progression! and! survival, ! NALM6ICXCR4IKO! and! NALM6IWT! cells! were!introduced! into! NSG! mice! and! disease! progression! monitored.! It ! was!observed! that!CXCR4!deletion!significantly!reduced! leukemia!burden!and!progression! supporting! the! conventional! role! of! CXCL12! as! a! preIB! cell !growth! factor! and! the! role! of! CXCL12/CXCR4! in! BIcell ! lymphopoiesis. !Significantly! reduced! bone! marrow! infiltration/retention! in! mice! that!were! injected! with! CXCR4! knockout! cells! as! compared! to! the! wild! type!counterparts! validated! our! in! vitro! PEP! experiments. ! Most! importantly, !the! mice! injected! with! CXCR4! Knockout! cells! survived! significantly!longer! than! the! mice! injected! with! CXCR4! Wild! type! cells, ! highlighting!the!importance!of!this!axis!in!leukemia!prognosis. !
Previously, ! studies! have! reported! that! higher! CXCR4! expression! is!associated! with! worse! outcome! in! patients! with! BIALL(57,! 59). ! In!contrast, !our!analyses! in! the!patient!data!set!did!not! reveal!a!correlation!between! CXCR4! expression! and! patient! outcome.! However, ! it ! was!
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observed! that! the! patient! set! was! also! not! correlated! with! established!prognostic! markers! such! as! LDH.! Additionally, ! as! mentioned! earlier! the!entirety! of! CXCR4! expression! and! function! is! not! represented! by! a! one!time! quantification.! All ! patient! samples! had! CXCR4! measured! in! bone!marrow! aspirates! at! diagnosis! using! flow! cytometry.! It ! has! been!previously!demonstrated! that!BIALL!cells!express!higher! levels!of!CXCR4!in! peripheral! blood! and! lower! levels! in! the! bone! marrow! due! to!internalization! of! CXCR4.! Ten! patients! were! found! in! our! study! with!CXCR4! measured! in! both! bone! marrow! and! peripheral! blood.! Indeed,!barring! one! patient, ! nine! patients! had! CXCR4! levels! lower! in! the! bone!marrow.! However, ! no! significance! was! achieved! due! to! low! patient!numbers. !
On! the! other! hand,! worse! patient! outcome! was! associated! with!bone!marrow!blast! percentage.! Since! it ! has! been! established! in! previous!studies! that! CXCR4! antagonists! successfully! mobilize! BIALL! cells! from!the! bone! marrow(45,! 85,! 86), ! the! inclusion! of! CXCR4! antagonists! could!be!of!potential!therapeutic!value. !
In! summary,! our! study! validates! the! role! of! CXCR4! in! the!pathogenesis! of! BIALL! by! demonstrating! its! effect! on! migration,!adhesion! and! survival! of! leukemia! cells. ! We! show! that! this! mechanism!could! help! overcome! the! current! clinical! challenge! of! minimal! residual!disease! and! its! impending! outcome! of! relapse.! In! addition! to! inhibiting!
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! CXCR4! inhibitors! Plerixafor! (small! molecule)! and! BKT140!(peptide)! interfere! with! CXCR4! activation,! signaling! and! bone! marrow!homing! of! leukemia! cells. ! !Adhesion! of! BIALL! cells! to! bone! marrow!stromal!cell !(BMSC)!through!CXCR4/CXCL12!protects! leukemia!cells! from!cytotoxic! drugs, ! and! causes! cell ! adhesionImediated! drug! resistance!(CAMIDR).! Due! to! the! critical! role! of! the! CXCR4/CXCL12! axis! in! BIALL!cell ! adhesion! to! bone!marrow! stromal! cells! (BMSC),!we! hypothesize! that!targeting!CXCR4!will !attenuate!CAMIDR!in!BIALL.!
! All ! tested! BIALL! cell ! l ines! and! xenograftIexpanded! primary! cells!were! found! to! be! positive! for! surface! expression! of! CXCR4. ! !PreItreatment! with! Plerixafor/BKT140! significantly! inhibited! the!spontaneous! migration! of! BIALL! cells! beneath! BMSCs! in"
vitro !(Pseudoemperipolesis/PEP).! BIALL! cell ! l ine! and! xenograft!expanded! primary! BIALL! cell ! chemotaxis! towards! CXCL12! was! also!abrogated! by! preIincubation! with! Plerixafor! or! BKT140.! In! order! to!better!dissect!CXCR4! function! in!BIALL,!we!established! two!CXCR4!knock!out! cell ! l ines, ! TANOUEICXCR4IKO! and! NALM6ICXCR4IKO,! using! CRISPR!Cas9! technology.! Chemotaxis! to! CXCL12! and! PEP! beneath! BMSCs! was!significantly! decreased! for! CXCR4! knockout! cells! in! comparison! to! wild!type!controls!without!any!drug!treatment.!
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! We! showed! that! coIculture! with! BMSCs! rescued! BIALL! cells! in! the!supernatant! from! Dexamethasone! (DEX),! Vincristine! (VIN)! or!Cyclophosphamide! (4HC)! induced! cytotoxicity. ! Furthermore,! BIALL! cells!residing! under! the!BMSC! layer! (as! a! result! of! PEP)!were! highly! resistant!to! Dex/4HC/Vin! treatment. ! Targeting! CXCR4! significantly! inhibited! BIALL! chemotaxis! towards! CXCL12! gradient! and! PEP! beneath! BMSCs.!Consequently, ! chemoIsensitivity!assays!performed!with!a!combination!of!DEX/4HC/Vin! and! CXCR4! inhibitor! showed! enhanced! cytotoxicity! as!compared! to! DEX/4HC/Vin! alone.! BMSCs! rescued! NALM6! from! DEX!induced! cytotoxicity! but! failed! to! rescue! NALM6! CXCR4! KO,!indicating!that! CXCR4! is! the! central! mechanism! used! by! stromal! cells! to! provide!drug!resistance!to!ALL!cells. !! !We! extended! our! experiments! to! in" vivo"studies. ! 9! nonIirradiated! NSG!mice!per!group!were! injected!with!GFP+!NALM6!WT!or!NALM6!CXCR4!KO!cells! and! bioluminescent! Intensity! (BLI)! measured! at! day! 6, ! 10,! 14! and!17.!Mice! injected!with!NALM6!CXCR4!KO!had!significantly! less!BLI! signal!than!NALM6! WT! throughout! the! course! of! the! disease.! In! 3!representative! mice! per! group! sacrificed! on! day! 17,! flow! cytometry!demonstrated! that! NALM6! CXCR4! KO! injected! mice! had! less! leukemic!infiltration! in! bone! marrow! than! NALM6! WT.! Staining! by! CXCR4! 12G5!antibodies! revealed! the! lack! of! CXCR4! expression! in! mice! injected! with!NALM6!CXCR4!KO!compared! to!NALM6!WT.!The!proportion!of! circulating!
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! Corroborating! data! reported! by! Honczarenko! et! al ! (1999)(78), ! the!present! study! does! not! demonstrate! a! correlation! between! CXCR4!expression! and! CXCL12! responsiveness.! As! the! alternate! decoy! receptor!that!sequesters!CXCL12!away!from!CXCR4,!the!expression!and!function!of!CXCR7!could!be!one!way!to!regulate!functionality!of!CXCR4.!
! Conflicting!data!have!been!reported!regarding!expression!of!CXCR7!in! B! cells! where! some! studies! report! high! expression! of! the! receptor!(Infantino! et! al ! 2006)(87)! and! other! studies! demonstrating! complete!lack! of! the! CXCR7! protein! (88). ! The! availability! of! quality! antibodies! to!detect! the! surface! expression! of! CXCR7! is! a! major! challenge.! Similar!observations! have! been! made! with! other! cancers, ! for! example, !conflicting! data! has! been! reported! about! expression! of! CXCR7! in! breast!cancer. ! This! presents! a! challenge! to! identifying! a! robust! negative!control. !
! Furthermore,! plerixafor! has! been! reported! to! have! agonistic!activity! towards! CXCR7! and! shows! activation! of! GIprotein! independent!βIarrestin!signaling!leading!to!MAPK!activation(89). !
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! Identification! of! appropriate! negative/positive! controls! and!determination!of!CXCR7!expression! is!crucial! to! the!understanding!of! the!dynamics!of!CXCR4!function.!
Elucidation"of"the"CXCR4"signaling"mechanism"
! As! demonstrated! by! the! chemotaxis! and! pseudoemperipolesis!experiments, ! expression! of! CXCR4! is! crucial! in! BIALL! cell ! migration.!Additionally, !according!to!chemoIsensitivity!experiments!conducted!with!CXCL12! in! place! of! BMSC! coIculture! (Figure! 31), ! CXCR4! is! also! involved!in!providing!BIALL!cells!resistance!to!chemotherapy.!
! CXCR4! has! been! shown! to! activate! various! signaling! cascades, !however! it ! is! not! yet! fully! understood! which! signaling! regulators! is!responsible! for! migration! and! resistance! to! chemotherapy.! In! order! to!identify! novel! targets! and! stratify! patients! that! are! resistant! to! CXCR4!inhibitors, ! it ! is! essential ! better! understand! the! key! regulators!downstream! of! CXCR4! that! are! crucial! for! providing! chemotherapy!resistance!to!BIALL!cells. !
Addition"of"chemotherapy"to"in"vivo"experiments"
! Our! in" vivo" experiments! demonstrated! a! significant! increase! in!survival! of! mice! injected! with! BIALL! cells! lacking! CXCR4! expression! as!compared! to! mice! injected! with! wild! type! CXCR4! cells. ! Additionally, !leukemia!burden,!bone!marrow!infiltration!and!circulating!leukemia!cells!
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were! significantly! lower! in! mice! injected! with! CXCR4! knockout! cells!throughout!the!course!of!the!experiment. !
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